Safety and Efficacy Evaluation of IM23 CAR-T Cells (IM23CAR-T)
Clinical trial NCT03585517 · COMPLETED
Trial details
- NCT number
- NCT03585517
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-21
- Primary completion
- 2020-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.